An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants

NCT05653986 · clinicaltrials.gov ↗
COMPLETED
Status
391
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie